Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

PloS One
Fariba AhmadizarAnke H Maitland-van der Zee

Abstract

To evaluate the efficacy and safety of bevacizumab in the adjuvant cancer therapy setting within different subset of patients. PubMed, EMBASE, Cochrane and Clinical trials.gov databases were searched for English language studies of randomized controlled trials comparing bevacizumab and adjuvant therapy with adjuvant therapy alone published from January 1966 to 7th of May 2014. Progression free survival, overall survival, overall response rate, safety and quality of life were analyzed using random- or fixed-effects models according to the PRISMA guidelines. We obtained data from 44 randomized controlled trials (30,828 patients). Combining bevacizumab with different adjuvant therapies resulted in significant improvement of progression free survival (log hazard ratio, 0.87; 95% confidence interval (CI), 0.84-0.89), overall survival (log hazard ratio, 0.96; 95% CI, 0.94-0.98) and overall response rate (relative risk, 1.46; 95% CI: 1.33-1.59) compared to adjuvant therapy alone in all studied tumor types. In subgroup analyses, there were no interactions of bevacizumab with baseline characteristics on progression free survival and overall survival, while overall response rate was influenced by tumor type and bevacizumab dose (p-value:...Continue Reading

References

Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz KabbinavarEmily Bergsland
Aug 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YangSteven A Rosenberg
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonFairooz Kabbinavar
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy D MillerHope S Rugo
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Jan 31, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xiaolei ZhuChirag R Parikh
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce J GiantonioUNKNOWN Eastern Cooperative Oncology Group Study E3200
Sep 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A TangLillian L Siu
Dec 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-J MouradB I Levy
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckChristian Manegold
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemMalcolm J Moore
Nov 12, 2009·Journal of the National Cancer Institute·Kristine R Broglio, Donald A Berry
Feb 23, 2010·International Journal of Surgery·David MoherUNKNOWN PRISMA Group
Feb 27, 2010·American Journal of Hypertension·Vishal RanpuraShenhong Wu
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian I RiniEric J Small
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W MilesGilles Romieu
Jun 12, 2010·Journal of the American Society of Nephrology : JASN·Shenhong WuXiaolei Zhu
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hedy Lee KindlerRichard M Goldberg
Oct 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carmen J AllegraNorman Wolmark
Dec 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy E KemenyMichael I D'Angelica
Apr 8, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Fabio A B SchutzToni K Choueiri
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R SpigelMark A Socinski
Aug 17, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Atsushi OhtsuYoon-Koo Kang
Nov 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin B KimSteven J O'Day
Dec 30, 2011·The New England Journal of Medicine·Robert A BurgerUNKNOWN Gynecologic Oncology Group
Dec 30, 2011·The New England Journal of Medicine·Timothy J PerrenUNKNOWN ICON7 Investigators
Jan 17, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Seiji NihoUNKNOWN JO19907 Study Group
Jan 27, 2012·The New England Journal of Medicine·Gunter von MinckwitzUNKNOWN Arbeitsgemeinschaft Gynäkologische Onkologie–Breast Study Groups
Jan 27, 2012·The New England Journal of Medicine·Harry D BearNorman Wolmark

❮ Previous
Next ❯

Citations

Dec 5, 2015·Frontiers in Pharmacology·Anne-Florence BlandinMonique Dontenwill
Apr 24, 2016·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Melek K EryılmazHasan Ş Coşkun
Sep 2, 2017·Journal of the American Heart Association·Matthias TotzeckTienush Rassaf
Nov 13, 2018·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Yusuke KobayashiDaisuke Aoki
May 4, 2016·Médecine sciences : M/S·Yuchen GuMélanie Di Benedetto
Jan 6, 2019·International Journal of Clinical Pharmacy·Sara KavehKourosh Sayehmiri
Jan 5, 2021·JNCI Cancer Spectrum·Marina T Van LeeuwenClaire M Vajdic
Mar 19, 2020·Journal of Neuroradiology. Journal De Neuroradiologie·Chrysanthi PapagiannakiCharbel Mounayer
Sep 28, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D ArnoldI Chau

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.